Video yükleniyor...

Video Yüklenemedi

Bu video yüklenirken bir sorun oluştu. Bu geçici bir ağ sorunundan kaynaklanıyor olabilir veya video kullanılamıyor olabilir.

Ana Sayfaya Dön

Should very low-risk prostate cancer on active surveillance be considered a contraindication to anatomical enucleation? This patient had a >100 cc prostate with severe LUTS and bladder outlet obstruction, and a clear desire to be free from his urinary symptoms and improve his quality of life. We proceeded with... anatomical enucleation to prioritize symptom relief while preserving future oncologic options. Technical pearl: prior biopsies may create mild apical adhesions, but respecting the anatomical planes allows a standard enucleation. Don’t divide the bladder neck fibers until complete release and meticulous hemostasis are achieved. Would you operate, or continue surveillance alone? #HoLEP #BPH #ProstateCancer #ActiveSurveillance #Urologyshow more

DR CARVAJAL

5,009 subscribers

10,924 görüntüleme • 2 ay önce •via X (Twitter)

Anya Rossi• Live Now

Private livecam show

13 Yorum

Dr. Cleybismar Begot profil fotoğrafı

Dr. Cleybismar Begot2 ay önce

Great question. In my opinion these patients are great candidates to anatomical enucleation in selected cases of confined disease. I frequently deal post-TURP obstruction in cases with “funnel approach” .

Nathan L. Colon MD profil fotoğrafı

Nathan L. Colon MD2 ay önce

Extensive counseling/shared decision making key here. Radical prostatectomy likely over treatment and carries higher morbidity. My practice is to treat BPH/LUTS and monitor prostate cancer. I like robotic simple prostatectomy first line but any size appropriate procedure would be reasonable. I favor xrt if upstaged to clinically significant cancer but full spectrum of treatment options reviewed.

DR CARVAJAL profil fotoğrafı

DR CARVAJAL2 ay önce

Totally agree

Thanasis Apostolidis profil fotoğrafı

Thanasis Apostolidis2 ay önce

How old was the patient?

DR CARVAJAL profil fotoğrafı

DR CARVAJAL2 ay önce

57yo

Balaji Kalyanaraman profil fotoğrafı

Balaji Kalyanaraman2 ay önce

Not at all. I am routinely offering HoLEP to older (70 and above) patients with low/very low risk prostate cancer and bothersome LUTS.

Sonia Madrid profil fotoğrafı

Sonia Madrid2 ay önce

En mi opinión no es una contraindicacion. Ya hay evidencia al respecto, de que tiene beneficios en cuanto a la micción, sin que afecte el progreso de cáncer de próstata

Anand Badri, MD, FACS profil fotoğrafı

Anand Badri, MD, FACS2 ay önce

Not at all a contraindication I routinely disaggregate BPH from lower risk prostate cancer. No reason to have the patient suffer urinary symptoms in this setting. Offer a BPH surgery and continue surveillance afterwards.

DR CARVAJAL profil fotoğrafı

DR CARVAJAL2 ay önce

Totally agree

Rodrigo Juaneda profil fotoğrafı

Rodrigo Juaneda2 ay önce

Very nice surgery! I agree doing enucleation and AS.

Elio Sánchez-Ali profil fotoğrafı

Elio Sánchez-Ali2 ay önce

I support you, that’s what I should do.

崔家倫 Dr Alan Chui Ka Lun profil fotoğrafı

崔家倫 Dr Alan Chui Ka Lun2 ay önce

agrees, very low risk one is not "cancer" anyway, with bothersome symptoms, proceed to HoLEP

Mohamed El Komy profil fotoğrafı

Mohamed El Komy2 ay önce

This is art sir

Benzer Videolar

Dr. Abhishek Shukla (Senior Geriatrician) in conversation with Dr. Rohit Kapoor (MCh Urology) a senior urologist, to discuss a very common problem seen in elderly men—weak urine flow, frequent urination, and the feeling of incomplete bladder emptying.” Dr. Abhishek Shukla asked, “Many senior citizens complain that their urinary stream has become weak, urine comes drop by drop or intermittently, and they need to wake up multiple times at night to pass urine. Even after urinating, they feel that the bladder is not empty. What could be the reason?” Dr. Rohit Kapoor explained that these symptoms are most commonly related to the prostate gland. The prostate is a small gland located below the urinary bladder and surrounds the urinary passage (urethra). As men grow older, the prostate often enlarges and can obstruct the urine flow. He explained that this enlargement may be Benign Prostatic Hyperplasia (BPH), which is non-cancerous and very common with aging. In many cases, medicines can effectively control symptoms. However, an important point is that the size of the prostate alone does not decide treatment. A large prostate does not always need surgery if symptoms are controlled with medicines. On the other hand, even a smaller prostate can cause severe blockage and may require surgery if medicines fail. Dr. Kapoor also emphasized the importance of PSA (Prostate-Specific Antigen) testing for men above 50 years of age. Along with ultrasound and uroflowmetry, PSA helps detect prostate cancer early. He advised that every man above 50 should get a PSA test yearly. Dr. Abhishek Shukla concluded by reminding viewers that urinary problems should never be ignored. Early diagnosis and treatment can prevent complications and improve quality of life. Modern treatments, including advanced robotic surgery, now offer safer and highly precise solutions. #UrinaryHealth #Urology #pelvichealth #Incontinence #OveractiveBladder #BladderControl #BPH (Benign Prostatic Hyperplasia) #ProstateHealth #enlargedprostate #urinarytractinfection #uti #bladderhealth #urinarysystem #urology #urinary #urinaryincontinence #womenshealth #healthylifestyle #bladder #urologist

Dr. Abhishek Shukla (Senior Geriatrician) in conversation with Dr. Rohit Kapoor (MCh Urology) a senior urologist, to discuss a very common problem seen in elderly men—weak urine flow, frequent urination, and the feeling of incomplete bladder emptying.” Dr. Abhishek Shukla asked, “Many senior citizens complain that their urinary stream has become weak, urine comes drop by drop or intermittently, and they need to wake up multiple times at night to pass urine. Even after urinating, they feel that the bladder is not empty. What could be the reason?” Dr. Rohit Kapoor explained that these symptoms are most commonly related to the prostate gland. The prostate is a small gland located below the urinary bladder and surrounds the urinary passage (urethra). As men grow older, the prostate often enlarges and can obstruct the urine flow. He explained that this enlargement may be Benign Prostatic Hyperplasia (BPH), which is non-cancerous and very common with aging. In many cases, medicines can effectively control symptoms. However, an important point is that the size of the prostate alone does not decide treatment. A large prostate does not always need surgery if symptoms are controlled with medicines. On the other hand, even a smaller prostate can cause severe blockage and may require surgery if medicines fail. Dr. Kapoor also emphasized the importance of PSA (Prostate-Specific Antigen) testing for men above 50 years of age. Along with ultrasound and uroflowmetry, PSA helps detect prostate cancer early. He advised that every man above 50 should get a PSA test yearly. Dr. Abhishek Shukla concluded by reminding viewers that urinary problems should never be ignored. Early diagnosis and treatment can prevent complications and improve quality of life. Modern treatments, including advanced robotic surgery, now offer safer and highly precise solutions. #UrinaryHealth #Urology #pelvichealth #Incontinence #OveractiveBladder #BladderControl #BPH (Benign Prostatic Hyperplasia) #ProstateHealth #enlargedprostate #urinarytractinfection #uti #bladderhealth #urinarysystem #urology #urinary #urinaryincontinence #womenshealth #healthylifestyle #bladder #urologist

Association of International Doctors. (India).

25,997 görüntüleme • 3 ay önce

In the UK right now, there’s a bid to mandate the ENTIRE population have synthetic folate introduced into their nations food supply. They even want it in wholemeal flour. But this scientist found a 2.6 x increased risk of prostate cancer from increased folic acid. Jeremy Clarkson is campaigning for more screening. That screening might end up doing MORE harm than good. Because the men get tested end up going down the road of standard of care treatments, causing life altering surgery, who would have only died WITH signs of prostate cancer... not FROM it. The quality of life from standard of care is devastating: Dr Clare Craig - “It takes men, who would have died WTIH prostate cancer... without knowing they had prostate cancer... without any horrible interventions and surgery... and puts them through all that... and fails to impact on overall mortality...” “When you have your prostate out, 4 in 5 men will end up impotent.... and 1 in 5 will end up incontinent” Those 2 campaigns working in parallel, become a sort of Double Whammy. A campaign mandating the entire population receive a synthetic product potentially increasing the rate of prostate cancer. The other campaign increasing the people found through screening, leading to life altering standard of care treatments. It reminds me of that study in Sweden, showing more Sun exposure led to women living longer... but they push universal sunscreen use. And those women who lived longer didn’t die from Melanoma even though it was found more. Dr. Claire Craig - “If you are exposed to folic acid... your risk of prostate cancer is more than DOUBLED... If you care about prostate cancer, you need to campaign to get this stuff out of our flour” Jeremy Clarkson (Jeremy Clarkson) needs to watch this.

In the UK right now, there’s a bid to mandate the ENTIRE population have synthetic folate introduced into their nations food supply. They even want it in wholemeal flour. But this scientist found a 2.6 x increased risk of prostate cancer from increased folic acid. Jeremy Clarkson is campaigning for more screening. That screening might end up doing MORE harm than good. Because the men get tested end up going down the road of standard of care treatments, causing life altering surgery, who would have only died WITH signs of prostate cancer... not FROM it. The quality of life from standard of care is devastating: Dr Clare Craig - “It takes men, who would have died WTIH prostate cancer... without knowing they had prostate cancer... without any horrible interventions and surgery... and puts them through all that... and fails to impact on overall mortality...” “When you have your prostate out, 4 in 5 men will end up impotent.... and 1 in 5 will end up incontinent” Those 2 campaigns working in parallel, become a sort of Double Whammy. A campaign mandating the entire population receive a synthetic product potentially increasing the rate of prostate cancer. The other campaign increasing the people found through screening, leading to life altering standard of care treatments. It reminds me of that study in Sweden, showing more Sun exposure led to women living longer... but they push universal sunscreen use. And those women who lived longer didn’t die from Melanoma even though it was found more. Dr. Claire Craig - “If you are exposed to folic acid... your risk of prostate cancer is more than DOUBLED... If you care about prostate cancer, you need to campaign to get this stuff out of our flour” Jeremy Clarkson (Jeremy Clarkson) needs to watch this.

Humanspective

26,291 görüntüleme • 3 ay önce

Ozempic and other GLP1 drugs have been helpful for a lot of people. But when you start prescribing them to nearly 40 million Americans, you have to expect complications and side effects, like with any medication. About 4% of people experience serious gastrointestinal complications, and nearly 75% have symptoms like nausea, vomiting, or diarrhea. When you do the math, that adds up to over a million people dealing with serious GI issues alone. And for some, the complications are severe… bowel obstruction that can require emergency surgery, pancreatitis, sepsis, even life-threatening outcomes. So while these drugs can be effective, they are not risk-free. Without addressing food quality, protein intake, strength training, and lifestyle, the weight comes back and the risks remain.

Ozempic and other GLP1 drugs have been helpful for a lot of people. But when you start prescribing them to nearly 40 million Americans, you have to expect complications and side effects, like with any medication. About 4% of people experience serious gastrointestinal complications, and nearly 75% have symptoms like nausea, vomiting, or diarrhea. When you do the math, that adds up to over a million people dealing with serious GI issues alone. And for some, the complications are severe… bowel obstruction that can require emergency surgery, pancreatitis, sepsis, even life-threatening outcomes. So while these drugs can be effective, they are not risk-free. Without addressing food quality, protein intake, strength training, and lifestyle, the weight comes back and the risks remain.

Mark Hyman, M.D.

37,243 görüntüleme • 8 ay önce

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

A New Dawn in the Cancer War: Pioneering "BioShield" Technology Achieves Long-Term Remission Where Others Failed A stunning revelation from Dr. Patrick Soon-Shiong on the dawn of a new medical era. He details a breakthrough he calls "BioShield," a technology designed to prevent cancer by fundamentally educating the body's own immune system. Forget conventional vaccines. This isn't about antibodies. This is about creating a living, intelligent defense system within you. Here’s the concept: "BioShield" educates your T-cells to become elite "memory" cells. They then hide in your bone marrow, lying in wait. When a cancerous cell appears, they emerge to seek and destroy it—stopping cancer before it can ever gain a foothold. This isn't science fiction. It's peer-reviewed, published science with the National Cancer Institute (NCI). And the results are nothing short of remarkable: ➡️ Bladder Cancer: Patients who failed all other treatments and faced radical bladder removal have achieved complete remission for nine years after a simple injection. No surgery. Just a functional cure. ➡️ Pancreatic Cancer: A disease with a grim prognosis, now seeing patients disease-free for five years. The late Senator Harry Reid, after being told by others not to pursue it, saw his tumor markers normalize and lived two active, cancer-free years. ➡️ Merkel Cell Carcinoma & Head/Neck Cancer: Stories of complete responses in patients given weeks to live, with one living nine years and another saved from hospice when his ulcerating tumor melted away. Dr. Soon-Shiong is reframing the conversation. This isn't a "vaccine" in the traditional sense. It's Project BioShield—a proactive, cellular guardian for the body. The takeaway? We are transitioning from toxic, reactive cancer therapies to intelligent, preemptive protection. The age of the immune system as our most powerful shield against cancer has arrived. What are your thoughts on this "BioShield" approach to cancer?

Camus

31,256 görüntüleme • 10 ay önce

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Medical pioneer Dr. Patrick Soon-Shiong unveils a paradigm-shifting approach to cancer treatment that could save millions of lives. In an interview, he revealed we already have the key: protecting the immune system FIRST. The current standard of care—chemotherapy and radiation—often destroys a patient’s lymphocytes (NK & T cells), leading to a condition called lymphopenia. For decades, over 300 studies have shown that lymphopenia predicts early mortality, not just in cancer, but in sepsis and trauma. We treat anemia, but we’ve NEVER had an approved treatment for this critical immune deficiency. Until now. Dr. Soon-Shiong’s “Bio-Shield” is that breakthrough. It’s already approved, and the results are profound: Prostate cancer patients treated with the Bio-Shield before radiation achieved complete remission while their lymphocytes were protected. An ovarian cancer patient received the full, brutal course of chemo after the Bio-Shield. Her cancer disappeared, and she proceeded to surgery with a protected immune system. The vision is simple, yet revolutionary: Mandate that ANY patient undergoing radiation or chemotherapy first receives the Bio-Shield to protect their immune system. The treatment isn’t just attacking the cancer; it’s fortifying the body’s own innate ability to fight and survive. The call to action is clear. We don't need to wait for new regulatory hurdles. We need immediate education for doctors and patients across the nation. We have the power to turn the tide. This is the future of medicine: treating the patient's immune system as the most valuable asset in the fight for their life.

Camus

38,936 görüntüleme • 1 yıl önce

*Senator Harry Reid given a few days to live prior to meeting Dr Shiong&Bioshield* DR. SHIONG: Senator Reid, who came to see me after having failed all other treatment with his pancreatic cancer spread to his liver, came to see me and he said to me, “Patrick, I’m here. But I checked with Francis Collins who said, don’t go.” I said, “Well, Senator Reid, it’s your choices.” “I’m coming.” And we gave him the therapy and his CA19 went down to normal. And he lived for two years free of disease. He actually came, was very active. Dr. Shiong has spent the past eight years urgently sacrificing to bring this medication to the public. You should not need to be a politician, or millionaire or a senator to protect your child, your spouse, your father, or your mother. If you care about the people you love—and if you are tired of governments interfering not only with your health but with your very right to live—then itake a stand. Please, share this message with others. Bioshield can protect our families and preserve our lives.

Senator Harry Reid given a few days to live prior to meeting Dr Shiong&Bioshield DR. SHIONG: Senator Reid, who came to see me after having failed all other treatment with his pancreatic cancer spread to his liver, came to see me and he said to me, “Patrick, I’m here. But I checked with Francis Collins who said, don’t go.” I said, “Well, Senator Reid, it’s your choices.” “I’m coming.” And we gave him the therapy and his CA19 went down to normal. And he lived for two years free of disease. He actually came, was very active. Dr. Shiong has spent the past eight years urgently sacrificing to bring this medication to the public. You should not need to be a politician, or millionaire or a senator to protect your child, your spouse, your father, or your mother. If you care about the people you love—and if you are tired of governments interfering not only with your health but with your very right to live—then itake a stand. Please, share this message with others. Bioshield can protect our families and preserve our lives.

Dr. Kash Sarabi

101,351 görüntüleme • 1 yıl önce

From 82-84 with pain to 86-88 T90 pain-free 🔥⁠ ⁠ A remote athlete update from Performance Coach Ryan Kirk ⁠ After a tough sophomore season struggling with arm pain and sitting around 82-84, Derek Peterson had a big-time breakthrough, sitting 86-88 and grabbing his first 90 with no pain (yes, it was a ball). ⁠ ⁠ Two main things we attacked to get to where we are now:⁠ ⁠ 1. Pushy arm action⁠ ⁠ Derek was basically throwing the ball like a dart. So the main focus over the fall was learning how to pull the ball into release using drills like the Pivot Pick, Lasso, and Ten Toes, along with cues like “let your body throw the arm” and “let the arm lag behind the body.”⁠ ⁠ Derek figured it out pretty quickly, and we were heading in the right direction until “pulling the arm into release” turned into him yanking his head glove side and flying out with the arm. From there, we had to take a step back and clean up some range and tissue quality in the neck, bicep/tricep, pec, and shoulder, as well as re-learn how to pull into release while keeping his head on the target.⁠ ⁠ 2. Loading the back hip⁠ ⁠ Derek was also dumping into the quad, which was causing him to extend out of his back hip and had some influence on the pushy arm action as well. It took a lot of trial and error, but the key drills that seemed to help him get a feel for this were the drop step, hop into, and hover drills.⁠ ⁠ Both of these components are still a work in progress, but I'm stoked to see all of his hard work finally start to pay off and to see him continue to improve moving forward!⁠ ⁠ -Ryan⁠

From 82-84 with pain to 86-88 T90 pain-free 🔥⁠ ⁠ A remote athlete update from Performance Coach Ryan Kirk ⁠ After a tough sophomore season struggling with arm pain and sitting around 82-84, Derek Peterson had a big-time breakthrough, sitting 86-88 and grabbing his first 90 with no pain (yes, it was a ball). ⁠ ⁠ Two main things we attacked to get to where we are now:⁠ ⁠ 1. Pushy arm action⁠ ⁠ Derek was basically throwing the ball like a dart. So the main focus over the fall was learning how to pull the ball into release using drills like the Pivot Pick, Lasso, and Ten Toes, along with cues like “let your body throw the arm” and “let the arm lag behind the body.”⁠ ⁠ Derek figured it out pretty quickly, and we were heading in the right direction until “pulling the arm into release” turned into him yanking his head glove side and flying out with the arm. From there, we had to take a step back and clean up some range and tissue quality in the neck, bicep/tricep, pec, and shoulder, as well as re-learn how to pull into release while keeping his head on the target.⁠ ⁠ 2. Loading the back hip⁠ ⁠ Derek was also dumping into the quad, which was causing him to extend out of his back hip and had some influence on the pushy arm action as well. It took a lot of trial and error, but the key drills that seemed to help him get a feel for this were the drop step, hop into, and hover drills.⁠ ⁠ Both of these components are still a work in progress, but I'm stoked to see all of his hard work finally start to pay off and to see him continue to improve moving forward!⁠ ⁠ -Ryan⁠

Tread Athletics

16,586 görüntüleme • 2 yıl önce

All the tributes I've read about the dearly departed got me thinking about how, a lot of times, we wait until the funeral to give people their flowers... instead of while they are still alive to smell them. So, I want to be intentional about appreciating people who have had a profound influence and impact on my life while they are here. Today, I want to celebrate one of my mentors, Egbon Leke Alder. I'm a fiend for wisdom, and you would be hard pressed to find a mind wiser than his on this planet. My wife and I are convinced that he uses more of his brain power than most human beings. His intelligence is divine, his creativity is sublime, and his kindness? Truly, one of a kind. He is a genius in every sense of the word. When we were planning our campaign, I knew I had to "sit at his feet." I had no idea he was battling illness because he always found time to meet with my team and I repeatedly. He gave us counsel, strategy, and wisdom - the kind that even if you could put a price on it, we could never afford to pay. I didn't end up winning the election, but spending quality time with one of the greatest minds in Nigerian history? That's a win every single time and a personal highlight in my life. Egbon, I can offer you nothing but the prayers of a grateful heart. May God continue to prosper, protect, and preserve you. May He give you the desires of your heart and reward you for me. May the rest of your years be the best of them, and may the peace that passes all understanding guard your heart and mind in Christ Jesus. Thank you for believing in me, Sir. I hope to one day repay your faith by what I do and who I become, by the grace of God. Also, please buy his book.

All the tributes I've read about the dearly departed got me thinking about how, a lot of times, we wait until the funeral to give people their flowers... instead of while they are still alive to smell them. So, I want to be intentional about appreciating people who have had a profound influence and impact on my life while they are here. Today, I want to celebrate one of my mentors, Egbon Leke Alder. I'm a fiend for wisdom, and you would be hard pressed to find a mind wiser than his on this planet. My wife and I are convinced that he uses more of his brain power than most human beings. His intelligence is divine, his creativity is sublime, and his kindness? Truly, one of a kind. He is a genius in every sense of the word. When we were planning our campaign, I knew I had to "sit at his feet." I had no idea he was battling illness because he always found time to meet with my team and I repeatedly. He gave us counsel, strategy, and wisdom - the kind that even if you could put a price on it, we could never afford to pay. I didn't end up winning the election, but spending quality time with one of the greatest minds in Nigerian history? That's a win every single time and a personal highlight in my life. Egbon, I can offer you nothing but the prayers of a grateful heart. May God continue to prosper, protect, and preserve you. May He give you the desires of your heart and reward you for me. May the rest of your years be the best of them, and may the peace that passes all understanding guard your heart and mind in Christ Jesus. Thank you for believing in me, Sir. I hope to one day repay your faith by what I do and who I become, by the grace of God. Also, please buy his book.

Banky Wellington

104,535 görüntüleme • 2 yıl önce

Fenbendazole & Cancer Remission: The Peer-Reviewed Cases Challenging Modern Oncology A peer-reviewed medical publication has delivered a bombshell that the mainstream oncology world cannot ignore. It documents three cases of patients with advanced, metastatic cancer who achieved remarkable remissions after a radical course of action: self-medicating with veterinary-grade medication. The paper details three individuals who were essentially out of conventional options: ➡️ Case 1: An 83-year-old woman with stage 4 breast cancer that had spread to her liver, lungs, and bones. After refusing chemotherapy and entering hospice care, she began a regimen of fenbendazole (a dewormer for dogs), Vitamin D, and multivitamins. By June 2022, her cancer was in complete remission. She has been cancer-free for over three years. ➡️ Case 2: A man with stage 4 prostate cancer and extensive bone metastases. While on standard hormone therapy, he added high-dose fenbendazole and a cocktail of supplements (Vitamin K2, magnesium, melatonin, curcumin). The result? Within 26 months, his cancer growth and spread had completely halted. ➡️ Case 3: A man in his 60s with advanced melanoma, slated for immunotherapy. While waiting for treatment, he began the same fenbendazole and vitamin protocol. By February 2024, before even starting the planned drug, his cancer had completely disappeared. The Critical Nuance Everyone Must Understand: The authors of this paper are NOT advocating for patients to self-medicate with veterinary drugs. The purpose of publishing these cases is precisely the opposite: to sound an alarm. When patients in desperate situations feel compelled to turn to clandestine, unapproved treatments, it is a clear sign that current options are failing them. This paper uses these dramatic "success stories" as a powerful call to action for the scientific community to launch proper clinical trials. The central question is no longer just if cancer metabolism can be targeted, but how we can safely and effectively harness these pathways. The combination of a repurposed drug with foundational lifestyle and nutritional support (the common denominator in all three cases) presents a compelling, albeit unorthodox, avenue for research. This is where the conversation about medical freedom, patient desperation, and scientific rigor collides. It underscores an urgent need to explore all promising pathways, especially those that are patient-driven, with the rigor they deserve. What are your thoughts on the role of repurposed drugs in modern oncology?

Fenbendazole & Cancer Remission: The Peer-Reviewed Cases Challenging Modern Oncology A peer-reviewed medical publication has delivered a bombshell that the mainstream oncology world cannot ignore. It documents three cases of patients with advanced, metastatic cancer who achieved remarkable remissions after a radical course of action: self-medicating with veterinary-grade medication. The paper details three individuals who were essentially out of conventional options: ➡️ Case 1: An 83-year-old woman with stage 4 breast cancer that had spread to her liver, lungs, and bones. After refusing chemotherapy and entering hospice care, she began a regimen of fenbendazole (a dewormer for dogs), Vitamin D, and multivitamins. By June 2022, her cancer was in complete remission. She has been cancer-free for over three years. ➡️ Case 2: A man with stage 4 prostate cancer and extensive bone metastases. While on standard hormone therapy, he added high-dose fenbendazole and a cocktail of supplements (Vitamin K2, magnesium, melatonin, curcumin). The result? Within 26 months, his cancer growth and spread had completely halted. ➡️ Case 3: A man in his 60s with advanced melanoma, slated for immunotherapy. While waiting for treatment, he began the same fenbendazole and vitamin protocol. By February 2024, before even starting the planned drug, his cancer had completely disappeared. The Critical Nuance Everyone Must Understand: The authors of this paper are NOT advocating for patients to self-medicate with veterinary drugs. The purpose of publishing these cases is precisely the opposite: to sound an alarm. When patients in desperate situations feel compelled to turn to clandestine, unapproved treatments, it is a clear sign that current options are failing them. This paper uses these dramatic "success stories" as a powerful call to action for the scientific community to launch proper clinical trials. The central question is no longer just if cancer metabolism can be targeted, but how we can safely and effectively harness these pathways. The combination of a repurposed drug with foundational lifestyle and nutritional support (the common denominator in all three cases) presents a compelling, albeit unorthodox, avenue for research. This is where the conversation about medical freedom, patient desperation, and scientific rigor collides. It underscores an urgent need to explore all promising pathways, especially those that are patient-driven, with the rigor they deserve. What are your thoughts on the role of repurposed drugs in modern oncology?

Camus

50,547 görüntüleme • 10 ay önce

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Joe Tippens

10,790 görüntüleme • 6 gün önce

A stunning account from Dr. Patrick Soon-Shiong reveals a catastrophic failure at the FDA, where bureaucratic indifference and potential conflicts of interest are blocking a groundbreaking cancer treatment. His drug, already approved for a form of bladder cancer, is a unique natural protein therapy that activates the body's own immune system (natural killer cells, T-cells). It has shown remarkable long-term results, preserving patients' bladders for over a decade and avoiding radical, high-mortality surgery. Yet, when seeking a simple label expansion for another bladder cancer indication—a logical step—the FDA "Refused to File." In a desperate meeting, Dr. Soon-Shiong confronted two senior reviewers. He posed a heartfelt question: If his own father had bladder cancer, and this safe, approved drug could save his bladder, why wouldn't they give him that chance? Their chilling response: "I don't care." Pushed for rationale, they fell back on outdated dogma: "This is how we've done it for years." They demanded a comparative trial against chemotherapy, which he argued is unethical. Chemotherapy destroys immune memory and carries severe risks, while his treatment offers durable freedom. Weeks later, the hypocrisy was exposed. Johnson & Johnson received a "Priority Review" for a bladder cancer chemotherapy—a treatment with a 1% mortality rate and a 24% rate of devastating low lymphocyte counts. Why the discrepancy? Dr. Soon-Shiong’s drug, despite its breakthrough status, was denied the same priority. This begs the question: Is the "revolving door" between the FDA and Big Pharma putting corporate profits over patient lives? Even with well-intentioned leaders like Bobby Kennedy and Dr. Marty Makary, the entrenched bureaucracy seems immune to both scientific evidence and human compassion. Patients are being left behind, and innovators are being stiff-armed, all while the old, toxic guard is given the red-carpet treatment. This is more than a story of one drug; it's a systemic crisis in American medicine.

A stunning account from Dr. Patrick Soon-Shiong reveals a catastrophic failure at the FDA, where bureaucratic indifference and potential conflicts of interest are blocking a groundbreaking cancer treatment. His drug, already approved for a form of bladder cancer, is a unique natural protein therapy that activates the body's own immune system (natural killer cells, T-cells). It has shown remarkable long-term results, preserving patients' bladders for over a decade and avoiding radical, high-mortality surgery. Yet, when seeking a simple label expansion for another bladder cancer indication—a logical step—the FDA "Refused to File." In a desperate meeting, Dr. Soon-Shiong confronted two senior reviewers. He posed a heartfelt question: If his own father had bladder cancer, and this safe, approved drug could save his bladder, why wouldn't they give him that chance? Their chilling response: "I don't care." Pushed for rationale, they fell back on outdated dogma: "This is how we've done it for years." They demanded a comparative trial against chemotherapy, which he argued is unethical. Chemotherapy destroys immune memory and carries severe risks, while his treatment offers durable freedom. Weeks later, the hypocrisy was exposed. Johnson & Johnson received a "Priority Review" for a bladder cancer chemotherapy—a treatment with a 1% mortality rate and a 24% rate of devastating low lymphocyte counts. Why the discrepancy? Dr. Soon-Shiong’s drug, despite its breakthrough status, was denied the same priority. This begs the question: Is the "revolving door" between the FDA and Big Pharma putting corporate profits over patient lives? Even with well-intentioned leaders like Bobby Kennedy and Dr. Marty Makary, the entrenched bureaucracy seems immune to both scientific evidence and human compassion. Patients are being left behind, and innovators are being stiff-armed, all while the old, toxic guard is given the red-carpet treatment. This is more than a story of one drug; it's a systemic crisis in American medicine.

Camus

188,488 görüntüleme • 1 yıl önce

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

405,870 görüntüleme • 1 yıl önce

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

Can Fenbendazole Cure Cancer? According to a case series published in an oncology journal, the answer could be a resounding yes. The case report highlights three cancer patients who were in pretty bad shape. But after taking fenbendazole, they all experienced a complete remission. What Is Fenbendazole, and How Does it Work? Fenbendazole (FBZ) is a medicine originally designed to treat worms and parasites in animals. Its sister drugs, Mebendazole and Albendazole, have had remarkable success treating similar ailments in humans with few side effects. Recently, anecdotal reports have praised fenbendazole as a potentially miraculous anti-cancer drug. It works by destabilizing microtubules, the structures that help cancer cells divide and grow. By disrupting this process, fenbendazole effectively halts cancer cell division and slows or stops tumor growth. Miraculous Recoveries After Taking Fenbendazole Case series #1 features a 63-year-old man with advanced kidney cancer (clear cell renal carcinoma) who experienced tumor recurrence and severe side effects from multiple cancer therapies, including surgery and two different medications. With no effective options left, he turned to fenbendazole (FBZ), taking 1 gram three times a week at a friend’s suggestion. Over the next 10 months, his tumors—including those in his pancreas and spine—showed near-complete resolution on imaging. Remarkably, he experienced no side effects from FBZ, and follow-up scans have shown no signs of recurrence. Case series #2 follows a 72-year-old man with metastatic urethral cancer that had spread to his lungs, lymph nodes, and brain. Despite undergoing multiple rounds of chemotherapy and radiation, one lymph node continued to grow, resisting all treatments. Seeking alternatives, he decided to try fenbendazole (FBZ), taking 1 gram three times a week, along with vitamin E, curcumin, and CBD oil, while postponing further conventional therapies. Over the next nine months, imaging revealed a dramatic response, with the lymph node shrinking significantly until it completely resolved. Remarkably, he reported no side effects during this period. Case series #3 focuses on a 63-year-old woman diagnosed with a large, invasive bladder tumor. Facing a challenging prognosis, she underwent chemotherapy while also taking fenbendazole (FBZ) at 1 gram three times a week. After completing six cycles of treatment, follow-up scans showed a complete resolution of the tumor, with only minimal thickening remaining in the bladder wall. Confident in her recovery, she chose to decline further surgery and remains disease-free under regular surveillance. The abstract concluded, “FBZ appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.” Reflecting on these remarkable case reports, Dr. John Campbell (John Campbell) urged drug regulators to “start looking at this as a matter of some urgency because people are dying from cancer now.” “So if something is safe and effective, surely it can be accredited for human use by our national authorizing agencies pretty quickly if they want to,” Dr. Campbell added with a hint of sarcasm. Of course, the key words here are “if they want to.” “Three patients, basically… cured of their cancers. Read the paper for yourself. That’s what they seem to be saying to me.”

The Vigilant Fox 🦊

1,480,157 görüntüleme • 1 yıl önce

When a coach has health complications they are given grace by the media and the public because they are understanding of what they are fighting through. Deion Sanders he’s not been afforded that same empathy at Colorado this year. Despite being diagnosed with cancer, having his bladder removed and having a procedure in the middle of the season to alleviate blood clots, the tear downs of the man and his program have been relentless. The X’s and the O’s have to improve, but we can’t forget the human element of what has happened in Deion Sanders life this year. Coach Prime’s story was never meant to be perfect. It was meant to be powerful. And powerful it has been. With his Son’s not playing at Colorado, Coach Prime could have easily said, I’m done. I’ve had some health issues, Shedeur is in a bad situation in Cleveland, Shilo isn’t on a NFL roster and this just isn’t worth it anymore. But he didn’t because he made a commitment to every kid in his program and their parents that he was dedicated to building them into a complete man on and off the field. So at 3-6. Colorado, now is not the time to give up on Coach Prime. Now is the time to stand tall with him. Full episode here #RG3 #OuttaPocket #GoBuffs #CoachPrime

When a coach has health complications they are given grace by the media and the public because they are understanding of what they are fighting through. Deion Sanders he’s not been afforded that same empathy at Colorado this year. Despite being diagnosed with cancer, having his bladder removed and having a procedure in the middle of the season to alleviate blood clots, the tear downs of the man and his program have been relentless. The X’s and the O’s have to improve, but we can’t forget the human element of what has happened in Deion Sanders life this year. Coach Prime’s story was never meant to be perfect. It was meant to be powerful. And powerful it has been. With his Son’s not playing at Colorado, Coach Prime could have easily said, I’m done. I’ve had some health issues, Shedeur is in a bad situation in Cleveland, Shilo isn’t on a NFL roster and this just isn’t worth it anymore. But he didn’t because he made a commitment to every kid in his program and their parents that he was dedicated to building them into a complete man on and off the field. So at 3-6. Colorado, now is not the time to give up on Coach Prime. Now is the time to stand tall with him. Full episode here #RG3 #OuttaPocket #GoBuffs #CoachPrime

Robert Griffin III

125,045 görüntüleme • 11 ay önce

Donald Trump on why he didn't want to be President in 1980: In a fascinating interview with Rona Barrett, a 34-year-old Donald Trump is asked if he would ever want to be President of the United States. His answer might surprise you: "I really don't believe I would, Rona. But I would like to see somebody as the president who could do the job." Trump explains why the most capable people stay away from politics: "Most men are frightened of politics today… The most capable people are not necessarily running for political office and that is a very sad commentary on the country. They head major corporations and they had this and that, but they are not running for political office." When Barrett pushes him on why he himself wouldn't run, given his wealth and accomplishments, Trump gives a revealing answer: "Because I think it's a very mean life. I would love and I would dedicate my life to this country, but I see it as being a mean life." He continues with a critique of the political process itself: "Somebody with wrong views and somebody with the kind of views that are maybe a little bit unpopular, which may be right but may be unpopular... wouldn't necessarily have a chance of getting elected against somebody with no great brain but a big smile. And that's a sad commentary for the political process." Trump points to television as the culprit, using a striking historical example: "The Abraham Lincolns of the world... Abraham Lincoln would probably not be electable today because of television. He was not a handsome man and he did not smile at all. He would not be considered to be a prime candidate for the presidency and that's a shame, isn't it?" Despite his reluctance to run himself, Trump expresses a strong belief in the power of the right leader: "There is one man that can turn this country around. I could tell you I know a number of people that would be excellent presidents… they're very, very competent, they're leaders, they have the respect of everybody, and they would be fabulous presidents. But they're not running for political office." What Trump said he'd rather do at the time: "What I would like to be involved in is trying to help choose somebody or working with a group of people whereby they put up a candidate who would be acceptable to be the president of the country."

Donald Trump on why he didn't want to be President in 1980: In a fascinating interview with Rona Barrett, a 34-year-old Donald Trump is asked if he would ever want to be President of the United States. His answer might surprise you: "I really don't believe I would, Rona. But I would like to see somebody as the president who could do the job." Trump explains why the most capable people stay away from politics: "Most men are frightened of politics today… The most capable people are not necessarily running for political office and that is a very sad commentary on the country. They head major corporations and they had this and that, but they are not running for political office." When Barrett pushes him on why he himself wouldn't run, given his wealth and accomplishments, Trump gives a revealing answer: "Because I think it's a very mean life. I would love and I would dedicate my life to this country, but I see it as being a mean life." He continues with a critique of the political process itself: "Somebody with wrong views and somebody with the kind of views that are maybe a little bit unpopular, which may be right but may be unpopular... wouldn't necessarily have a chance of getting elected against somebody with no great brain but a big smile. And that's a sad commentary for the political process." Trump points to television as the culprit, using a striking historical example: "The Abraham Lincolns of the world... Abraham Lincoln would probably not be electable today because of television. He was not a handsome man and he did not smile at all. He would not be considered to be a prime candidate for the presidency and that's a shame, isn't it?" Despite his reluctance to run himself, Trump expresses a strong belief in the power of the right leader: "There is one man that can turn this country around. I could tell you I know a number of people that would be excellent presidents… they're very, very competent, they're leaders, they have the respect of everybody, and they would be fabulous presidents. But they're not running for political office." What Trump said he'd rather do at the time: "What I would like to be involved in is trying to help choose somebody or working with a group of people whereby they put up a candidate who would be acceptable to be the president of the country."

History Nerd

217,785 görüntüleme • 5 ay önce

I spent two hours with top sports scientist Dr. Mike Israetel. Nothing was off the table. He thinks most adults should be on a GLP-1, 60-year-olds will look 22 by the late 2030s, and his P(doom) is close to zero. Our conversation went everywhere, from steroids to superintelligence. 8 moments I had to share: 1) The vast majority of American adults should be on a GLP-1 His pick is tirzepatide. He says the weight loss alone makes the case, but the bigger benefits are lower inflammation, better glucose control, and new cancer data. There are exceptions: having a sensitive GI tract, very low body weight, or bone density issues.

I spent two hours with top sports scientist Dr. Mike Israetel. Nothing was off the table. He thinks most adults should be on a GLP-1, 60-year-olds will look 22 by the late 2030s, and his P(doom) is close to zero. Our conversation went everywhere, from steroids to superintelligence. 8 moments I had to share: 1) The vast majority of American adults should be on a GLP-1 His pick is tirzepatide. He says the weight loss alone makes the case, but the bigger benefits are lower inflammation, better glucose control, and new cancer data. There are exceptions: having a sensitive GI tract, very low body weight, or bone density issues.

Julian Issa

42,352 görüntüleme • 13 gün önce

An update on Atlas ❤️ Yesterday Atlas had his heart scan, and the good news is that the vets could not see any obvious adult heartworms in his heart . Of course, this doesn’t completely rule out the possibility that there may be a few very small ones that are simply too difficult to see on the scan. This means that Atlas will need to undergo the injection treatment for heartworm as he has the immature worms circulating thru the body. Unfortunately, this treatment can be very harsh, so the vets are going to do everything they can to make sure Atlas is as strong and stable as possible before and during treatment, and that he is able to cope with it safely. Atlas also has a heart murmur, which is another reason why the vets are being especially careful with him. The really positive news is that Atlas is on his paws, he is eating well, and little by little we are getting through all the diagnostics to understand exactly what is wrong with him and, most importantly, to make a plan for his future. His damaged paw is being dressed and checked every day, and it is looking surprisingly positive. What initially looked much worse now gives us hope that we may be able to save his foot and avoid amputation. ❤️ So, with all your support, Atlas is doing well so far. But I want to be completely honest with you: the treatment ahead can be very harsh. Sadly, we have lost a dog before during this treatment. It is a treatment I absolutely hate. There are risks, and those risks are very real. Today we have another meeting with the vets, and we will see where we are and what the next steps will be. For now, Atlas is eating, standing on his paws, and fighting his way through this — one step at a time. Thank you, from the bottom of my heart, for supporting Atlas and giving him this chance. ❤️

An update on Atlas ❤️ Yesterday Atlas had his heart scan, and the good news is that the vets could not see any obvious adult heartworms in his heart . Of course, this doesn’t completely rule out the possibility that there may be a few very small ones that are simply too difficult to see on the scan. This means that Atlas will need to undergo the injection treatment for heartworm as he has the immature worms circulating thru the body. Unfortunately, this treatment can be very harsh, so the vets are going to do everything they can to make sure Atlas is as strong and stable as possible before and during treatment, and that he is able to cope with it safely. Atlas also has a heart murmur, which is another reason why the vets are being especially careful with him. The really positive news is that Atlas is on his paws, he is eating well, and little by little we are getting through all the diagnostics to understand exactly what is wrong with him and, most importantly, to make a plan for his future. His damaged paw is being dressed and checked every day, and it is looking surprisingly positive. What initially looked much worse now gives us hope that we may be able to save his foot and avoid amputation. ❤️ So, with all your support, Atlas is doing well so far. But I want to be completely honest with you: the treatment ahead can be very harsh. Sadly, we have lost a dog before during this treatment. It is a treatment I absolutely hate. There are risks, and those risks are very real. Today we have another meeting with the vets, and we will see where we are and what the next steps will be. For now, Atlas is eating, standing on his paws, and fighting his way through this — one step at a time. Thank you, from the bottom of my heart, for supporting Atlas and giving him this chance. ❤️

Galgos del Sol

23,720 görüntüleme • 7 gün önce